| JXHL2101062 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-05-27 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHB2400164 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2024-09-30 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
| JXHB2400108 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2024-06-14 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
| JXHL2300233 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-19 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300222 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-12 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2400197 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2024-08-07 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2400020 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2024-01-19 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300212 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-12 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHB2400160 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2024-09-30 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
| JXHB2400105 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2024-06-14 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
| JXHL2300231 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-18 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHB2200138 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-09-18 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
| JXHL2400184 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2024-08-07 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300241 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-22 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300214 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-12 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2400196 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2024-08-07 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2400016 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2024-01-19 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300221 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-12 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHL2300235 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2023-09-19 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| JXHB2200142 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-09-18 | | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc | | | view |
